Lisap Laboratori Cosmetici S.p.a.
✅ Low Risk
FEI: 3012453784 • Rescaldina, Milan • ITALY
FEI Number
3012453784
Location
Rescaldina, Milan
Country
ITALYAddress
Via Monte Lungo 59, , Rescaldina, Milan, Italy
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
CSTIC LBLG
The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.
Refusal History
Frequently Asked Questions
What is Lisap Laboratori Cosmetici S.p.a.'s FDA import refusal history?
Lisap Laboratori Cosmetici S.p.a. (FEI: 3012453784) has 2 FDA import refusal record(s) in our database, spanning from 7/22/2009 to 7/22/2009.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Lisap Laboratori Cosmetici S.p.a.'s FEI number is 3012453784.
What types of violations has Lisap Laboratori Cosmetici S.p.a. received?
Lisap Laboratori Cosmetici S.p.a. has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Lisap Laboratori Cosmetici S.p.a. come from?
All FDA import refusal data for Lisap Laboratori Cosmetici S.p.a. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.